Business Description
Vectorite Biomedical Inc
ISIN : TW0004170006
Description
Vectorite Biomedical Inc is a Taiwan-based diagnostic and research company. It prepares studies of adult healthy cells, cell preparation and application.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.95 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 19.21 | |||||
| Beneish M-Score | -2.92 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 26.5 | |||||
| 3-Year EBITDA Growth Rate | 56.2 | |||||
| 3-Year EPS without NRI Growth Rate | 53 | |||||
| 3-Year FCF Growth Rate | 63.2 | |||||
| 3-Year Book Growth Rate | 13.2 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.66 | |||||
| 9-Day RSI | 42.74 | |||||
| 14-Day RSI | 43.48 | |||||
| 6-1 Month Momentum % | -33.04 | |||||
| 12-1 Month Momentum % | -33.43 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 17.53 | |||||
| Quick Ratio | 16.74 | |||||
| Cash Ratio | 16 | |||||
| Days Inventory | 78.46 | |||||
| Days Sales Outstanding | 33.56 | |||||
| Days Payable | 17.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.3 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 29.4 | |||||
| Operating Margin % | -28.88 | |||||
| Net Margin % | -11.82 | |||||
| FCF Margin % | -6.19 | |||||
| ROE % | -1.51 | |||||
| ROA % | -1.44 | |||||
| ROIC % | -6.63 | |||||
| ROC (Joel Greenblatt) % | -8.65 | |||||
| ROCE % | -3.61 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 11.71 | |||||
| PB Ratio | 1.52 | |||||
| Price-to-Tangible-Book | 1.6 | |||||
| Price-to-Operating-Cash-Flow | 515.52 | |||||
| EV-to-EBIT | -27.94 | |||||
| EV-to-EBITDA | -64.64 | |||||
| EV-to-Revenue | 8.07 | |||||
| EV-to-FCF | -131.64 | |||||
| Price-to-Net-Current-Asset-Value | 3.25 | |||||
| Price-to-Net-Cash | 3.59 | |||||
| Earnings Yield (Greenblatt) % | -3.58 | |||||
| FCF Yield % | -0.52 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vectorite Biomedical Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 55.853 | ||
| EPS (TTM) (NT$) | -0.15 | ||
| Beta | 0.26 | ||
| Volatility % | 97.28 | ||
| 14-Day RSI | 43.48 | ||
| 14-Day ATR (NT$) | 0.499844 | ||
| 20-Day SMA (NT$) | 15.1375 | ||
| 12-1 Month Momentum % | -33.43 | ||
| 52-Week Range (NT$) | 11.55 - 27.2 | ||
| Shares Outstanding (Mil) | 43.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vectorite Biomedical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vectorite Biomedical Inc Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vectorite Biomedical Inc Frequently Asked Questions
What is Vectorite Biomedical Inc(ROCO:4170)'s stock price today?
The current price of ROCO:4170 is NT$14.95. The 52 week high of ROCO:4170 is NT$27.20 and 52 week low is NT$11.55.
When is next earnings date of Vectorite Biomedical Inc(ROCO:4170)?
The next earnings date of Vectorite Biomedical Inc(ROCO:4170) is .
Does Vectorite Biomedical Inc(ROCO:4170) pay dividends? If so, how much?
Vectorite Biomedical Inc(ROCO:4170) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers